MILD is often described as a way to avoid or delay traditional spine surgery for spinal stenosis, and there’s real data behind that claim. But it’s worth understanding honestly what that evidence does and doesn’t establish, because the full picture is more nuanced than a single statistic suggests.
The Strongest Data Point
The most frequently cited study, a long-term follow-up from the Cleveland Clinic, found that 88 percent of patients who underwent MILD avoided open surgical decompression at the same spinal level for at least five years afterward. That’s a meaningful, real finding, and it’s part of why Medicare and most major insurers cover the procedure.
What That Statistic Doesn’t Tell You
Here’s the more complete picture: independent systematic reviews of the broader MILD research base have described the overall quality of evidence as low, citing issues like small study sizes, lack of blinding, and limited comparison against a true placebo or sham procedure. This doesn’t mean MILD doesn’t work, it means the studies supporting it, taken as a whole, don’t yet meet the highest bar of clinical evidence, the kind that comes from large, blinded, placebo-controlled trials.
Why This Matters, and Why It Isn’t a Reason for Alarm
It’s worth being direct about this rather than glossing over it. A “low quality of evidence” rating in these reviews reflects study design limitations, not necessarily that the treatment fails to help patients. MILD has an excellent safety profile, similar to a routine epidural steroid injection, and the more robust studies that do exist, including a randomized trial comparing MILD plus conservative care to conservative care alone, show a real and statistically significant difference in favor of MILD. The honest summary is: MILD has real supportive evidence, including the 88 percent five-year surgery-avoidance figure, but that evidence base is still maturing, and higher-quality, industry-independent trials would strengthen the case further.
What This Means for You as a Patient
None of this should be read as a reason to avoid MILD. Its safety profile is well established, and for appropriately selected patients (those with stenosis caused specifically by a thickened ligament), the existing data is genuinely favorable. It simply means it’s fair to hold the “avoids back surgery” claim with realistic expectations rather than as an absolute guarantee, and worth discussing directly with your doctor what the evidence does and doesn’t show for someone with your specific presentation.
The Takeaway
MILD is a low-risk, well-covered procedure with real, supportive data behind its ability to help many patients avoid more invasive surgery, but “real” and “not yet fully proven at the highest evidence standard” can both be true at once. Understanding that distinction helps you go into the conversation with your doctor informed rather than either oversold or unnecessarily skeptical.